EMPLOYEE STOCK COMPENSATION (Tables)

9 Months Ended

Sep. 30, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary of Share-Based Compensation Expense

The following table presents share-based compensation expense and the related tax benefits for the periods indicated:



	Three Months Ended September 30,				Nine Months Ended September 30,
	2017		2016		2017		2016
	(In thousands)
Stock options	$	36	$	103	$	703	$	400
Restricted stock awards and units	2,185		2,716		9,167		8,110
Stock appreciation rights	—		2		42		17
Total share-based compensation expense	$	2,221	$	2,821	$	9,912	$	8,527
Related tax benefits	$	927	$	1,172	$	4,122	$	3,543

Unrecognized Share-Based Compensation Expense

The following table presents unrecognized share-based compensation expense as of September 30, 2017:



	September 30, 2017
	Unrecognized Expense		Weighted-Average Remaining Expected Recognition Period
	($ in thousands)
Stock option awards	$	662	3.1 years
Restricted stock awards and restricted stock units	11,049		2.5 years
Total	$	11,711	2.5 years

Option Activity

The following table represents stock option activity as of and for the three months ended September 30, 2017:



	Three Months Ended September 30, 2017
	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value (In thousands)
Outstanding at beginning of period	740,805		$	13.80	7.1 years	$	5,702
Exercised	(257,495	)	$	12.72	6.3 years
Forfeited	(77,337	)	$	13.97	7.3 years
Outstanding at end of period	405,973		$	14.46	7.1 years	$	2,555
Exercisable at end of period	204,541		$	13.62	6.2 years	$	1,458

The following table represents stock option activity as of and for the nine months ended September 30, 2017:



	Nine Months Ended September 30, 2017
	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value (In thousands)
Outstanding at beginning of period	968,591		$	13.95	6.4 years	$	3,336
Exercised	(389,281	)	$	12.54	6.1 years
Forfeited	(173,337	)	$	15.92	8.1 years
Outstanding at end of period	405,973		$	14.46	7.1 years	$	2,555
Exercisable at end of period	204,541		$	13.62	6.2 years	$	1,458

Nonvested Share

The following table represents changes in unvested stock options as of and for the three and nine months ended September 30, 2017:



	Three Months Ended September 30, 2017				Nine Months Ended September 30, 2017
	Number of Shares		Weighted-Average Exercise Price Per Share		Number of Shares		Weighted-Average Exercise Price Per Share
Outstanding at beginning of period	265,730		$	14.65	518,936		$	15.04
Vested	(17,627	)	$	13.03	(174,833	)	$	14.10
Forfeited	(46,671	)	$	12.41	(142,671	)	$	15.84
Outstanding at end of period	201,432		$	15.31	201,432		$	15.31

Restricted Stock and Restricted Stock Units Activity

The following table presents unvested restricted stock awards and restricted stock units activity as of and for the three and nine months ended September 30, 2017:



	Three Months Ended September 30, 2017				Nine Months Ended September 30, 2017
	Number of Shares		Weighted Average Grant Date Fair Value Per Share		Number of Shares		Weighted Average Grant Date Fair Value Per Share
Outstanding at beginning of period	1,050,314		$	17.85	1,417,144		$	16.16
Granted ⁽¹⁾	181,630		$	21.08	814,856		$	20.81
Vested	(76,380	)	$	15.42	(793,328	)	$	15.95
Forfeited ⁽¹⁾	(169,743	)	$	19.09	(452,851	)	$	17.93
Outstanding at end of period	985,821		$	18.34	985,821		$	18.34

(1)

The number of granted shares/units includes aggregate performance-based shares of 117,709 and 152,709, respectively, for the three and nine months ended September 30, 2017. The number of forfeited shares includes aggregate performance-based shares of 60,419 for the three and nine months ended September 30, 2017. The vesting of these awards is subject to certain performance targets and goals being met. These performance targets include conditions relating to the Company’s profitability and regulatory standing. The actual amounts of stock released upon vesting will be determined by the Compensation Committee of the Company's Board of Directors upon the Committee's certification of the satisfaction of the target level of performance.

Summary of all Outstanding SARs

The following table represents SARs activity as of and for the three months ended September 30, 2017:



	Three Months Ended September 30, 2017
	Number of Shares	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value (In thousands)
Outstanding at beginning of period	1,559,012	$	11.60	5.1 years	$	15,430
Outstanding at end of period	1,559,012	$	11.60	4.9 years	$	14,261
Exercisable at end of period	1,559,012	$	11.60	4.9 years	$	14,261

The following table represents SARs activity as of and for the nine months ended September 30, 2017:



	Nine Months Ended September 30, 2017
	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contract Term	Aggregated Intrinsic Value (In thousands)
Outstanding at beginning of period	1,559,047		$	11.60	5.6 years	$	8,961
Forfeited	(35	)	$	10.09	4.9 years
Outstanding at end of period	1,559,012		$	11.60	4.9 years	$	14,261
Exercisable at end of period	1,559,012		$	11.60	4.9 years	$	14,261

The following table represents changes in unvested SARs as of and for the three and nine months ended September 30, 2017:



	Three Months Ended September 30, 2017			Nine Months Ended September 30, 2017
	Number of Shares	Weighted-Average Exercise Price Per Share		Number of Shares		Weighted-Average Exercise Price Per Share
Outstanding at beginning of period	—	$	—	8,069		$	10.09
Vested	—	$	—	(8,034	)	$	10.09
Forfeited	—	$	—	(35	)	$	10.09
Outstanding at end of period	—	$	—	—		$	—